Clinical Trial Update: SPARK-ALL: Calaspargase Pegol in Adults With ALL [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial SPARK-ALL evaluating Calaspargase Pegol in adults with acute lymphoblastic leukemia was terminated (Phase 2/3).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• Calaspargase Pegol (calaspargase pegol)

Snippet

Sponsor: Institut de Recherches Internationales Servier | Conditions: Acute Lymphoblastic Leukemia | Phase 2, Phase 3 | Status: TERMINATED